Search results
Results from the WOW.Com Content Network
These side effects may occur in as many as 90% of men treated with bicalutamide monotherapy, [29] but gynecomastia is generally reported to occur in 70 to 80% of patients. [30] In the EPC trial, at a median follow-up of 7.4 years, breast pain and gynecomastia respectively occurred in 73.6% and 68.8% of men treated with 150 mg/day bicalutamide ...
A myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops in one of the coronary arteries of the heart, causing infarction (tissue death) to the heart muscle. [1] The most common symptom is retrosternal chest pain or discomfort that classically radiates to the left shoulder, arm, or jaw. [1]
Theories suggest a link between brain activation of stress-related biochemicals (including neuropeptides) and the effects these chemicals have on areas of the heart, especially neuropeptide Y. [26] Specifically, adrenal stimulation by the sympathetic nervous system has been seen in cases ranging from physical events such as ischemic stroke, to ...
A panic attack usually won’t cause a heart attack, but it is possible, according to the Cleveland Clinic. Chronic stress and high blood pressure can increase your risk for a heart attack or stroke.
The chances for surviving a heart attack depend on receiving immediate and timely care," she explains, adding that 80 percent of heart attacks can be prevented by taking healthy lifestyle measures.
Feb. 13—Sweating, nausea, dizziness and unusual fatigue may not sound like typical heart attack symptoms. However, they are common for women and may occur more often when resting or asleep.
Because chest pain and difficulty breathing are commonly symptoms of some sort of heart disease (such as a heart attack), there is medical importance in ruling out life-threatening reasons for their symptoms. [22] A heart attack (also called a myocardial infarction) occurs when there is a blockage in the arteries going to the heart, causing ...
The side effects of cyproterone acetate (CPA), a steroidal antiandrogen and progestin, including its frequent and rare side effects, have been studied and characterized.It is generally well-tolerated and has a mild side-effect profile, regardless of dosage, when it used as a progestin or antiandrogen in combination with an estrogen such as ethinylestradiol or estradiol valerate in women.